3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: August 13, 2019
Period of Report: August 13, 2019
Accession Number: 0001735276-19-000089

View Document ↗ View on SEC.gov ↗